BiologicTx® Unveils Proprietary Transplant Therapeutic Data Management System at the American Transplant Congress

BiologicTx Sequence™ Enables Transplant Clinicians to Better Understand the Therapeutic Impact of Progressive and Routine Protocols while Ensuring Compliance

Totowa, NJ – May 18, 2013 – BiologicTx®, the first solely focused infusion and pharmacy provider of biologic and oral transplant therapy management, today announced the unveiling of their new proprietary transplant therapeutic data management and analytics program, BiologicTx Sequence™. BiologicTx Sequence is a proprietary data management system that combines a patient’s drug therapy interventions with patient specific data to provide the clinician with a global picture of the therapeutic impact and efficacy of the treatment prescribed. BiologicTx Sequence aggregates into a unified database all physician, laboratory, pharmacy and nursing data into one, easy to use and manage database that optimizes patient care.